Themis Bioscience Overview

  • Founded
  • 2009

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.11B

Themis Bioscience General Information

Description

Themis Bioscience NV is an immunomodulation clinical-stage biopharmaceutical group that focuses on the development of products to protect against infectious diseases and for the treatment of cancer. The company has developed a vaccine platform and broad pipeline based on the advanced understanding of immune system mechanisms.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • Muthgasse 11/2
  • Vienna, 1190
  • Austria

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Themis Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 19-Jun-2020 $1.11B 000.00 00.000 Completed Generating Revenue
11. IPO 29-Apr-2020 000.00 00000 Cancelled Clinical Trials - Phase 2
10. Later Stage VC (Series D) 18-Sep-2019 000.00 000.00 Completed Generating Revenue
9. Grant 04-Jun-2019 000.00 000.00 Completed Generating Revenue
8. Grant 06-Mar-2018 0000 000.00 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series C) 04-Jan-2018 000.00 000.00 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series B) 29-Nov-2016 000.00 000.00 Completed Clinical Trials - Phase 2
5. Secondary Transaction - Private 01-Oct-2013 00.000 Completed Startup
4. Early Stage VC (Series A) 18-May-2011 $7.24M $8.61M Completed Startup
3. Grant 06-Jul-2010 $1.23M $1.37M Completed Startup
To view Themis Bioscience’s complete valuation and funding history, request access »

Themis Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Themis Bioscience NV is an immunomodulation clinical-stage biopharmaceutical group that focuses on the development of pr
Biotechnology
Vienna, Austria
40 As of 2020
000.00
0.000 0000-00-00
000000&0 000.00

000000

dunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
0000 000000000
Cambridge, MA
000
00.00 0000-00-00
00000000000 000

000000

dipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000 000000000
Boston, MA
0 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Themis Bioscience Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Venture Capital-Backed Cambridge, MA 000 00000000000 000
0000000 0000000000 Formerly VC-backed Boston, MA 0 00000 000000000 00000
000000000 00000000 Venture Capital-Backed Schlieren, Switzerland 00 000.00 00000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 000000000000 Formerly VC-backed Geneva, Switzerland 000.00 000000&0 000.00
You’re viewing 5 of 34 competitors. Get the full list »

Themis Bioscience Patents

Themis Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3673917-A1 Norovirus vaccines Pending 28-Dec-2018 0000000000
US-20220143175-A1 Norovirus vaccines Pending 28-Dec-2018 0000000000
EP-3807406-A1 Integrated manufacturing and chromatographic system for virus production Pending 15-Jun-2018 00000000
EP-3581646-A1 Integrated manufacturing and chromatographic system for virus production Pending 15-Jun-2018 00000000
US-20210254021-A1 Integrated manufacturing and chromatographic system for virus production Pending 15-Jun-2018 C12N7/00
To view Themis Bioscience’s complete patent history, request access »

Themis Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Themis Bioscience Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adjuvant Capital Impact Investing Minority 000 0000 000000 0
Austria Wirtschaftsservice Venture Capital Minority 000 0000 000000 0
Coalition for Epidemic Preparedness Innovations Corporation 000 0000 000000 0
FFG Finanzierungs- und Factorings Corporation Minority 000 0000 000000 0
Farallon Capital Management Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »